Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma

Chinese Journal of Cancer

Volumn 28, Issue 2, 2009, Pages 100-103

  Zhang, Zu Ping ^a   Sun, Yu Lan ^a   Fu, Li ^a   Gu, Feng ^a   Zhang, Lun ^a   Hao, Xi Shan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Chemosensitivity; Cisplatin; Head and neck neoplasm; Notch 1; Squamous cell carcinoma

Indexed keywords

CISPLATIN; NOTCH1 RECEPTOR;

ARTICLE; CANCER RESISTANCE; COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; GENE FUNCTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CISPLATIN; DIMETHYL SULFOXIDE; DRUG SCREENING ASSAYS, ANTITUMOR; EPITHELIUM; GAMMA-AMINOBUTYRIC ACID; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TRIGLYCERIDES; TUMOR CELLS, CULTURED;

EID: 70349501368     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Allenspach EJ, Maillard I, Aster JC, et al. Notch signaling in cancer [J]. Cancer Biol Ther, 2002,1(5):466-476.
2. Nefedova Y, Cheng P, Alsina M, et al. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines [J]. Blood, 2004,103(9):3503-3510.
3. Mungamuri SK, Yang X, Thor AD, et al. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53 [J]. Cancer Res, 2006,66(9):4715-4724.
4. Abiko T, Kawamura M, Izumi Y, et al. Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer [J]. Int J Hyperthermia, 2007,23(3):267-275.
5. Wang M, Li J, Zeng Y, et al. Expression and significance of Notch1, P21wAF1 and Involucrin in nasopharyngeal carcinoma [J]. Ai Zheng, 2005,24(10):1230-1234.
6. Shintani S, Hino S, Nakashiro K, et al. Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions [J]. Gan To Kagaku Ryoho, 2006,33(3):357-360.
7. Duan L, Yao J, Wu X, et al. Growth suppression induced by Notch1 activation involves Wnt-β-catenin down-regulation in human tongue carcinoma cells [J]. Biol Cell, 2006,98(8):479-490.
8. Shih IeM, Wang TL. Notch signaling, γ-secretase inhibitors, and cancer therapy [J]. Cancer Res, 2007,67(5):1879-1882.